What is the second-line treatment for depression?

What is the second-line treatment for depression?

• A. SSRI monotherapy at higher dose
• B. Benzodiazepines alone
• C. Combination of SSRI and venlafaxine (Effexor) or duloxetine (Cymbalta)
• D. Acetaminophen and caffeine

Answer: (C)

When a person with depression does not respond adequately to a first-line antidepressant at a therapeutic dose, increasing the depth of pharmacologic strategy is often the next move. Adding a second antidepressant with a different mechanism can yield a greater effect. Mixing an SSRI with a serotonin-norepinephrine reuptake inhibitor, such as venlafaxine or duloxetine, increases both serotonin and norepinephrine activity, targeting multiple neurotransmitter systems to enhance mood improvement. This dual-action approach is a common second-line step for resistant or partial-response depression. It’s important to monitor for increased side effects and risks like serotonin syndrome with this combination, hence it’s typically done under close supervision. In contrast, simply raising the SSRI dose may not provide additional benefit and can heighten adverse effects, benzodiazepines don’t treat the core depressive symptoms on their own, and acetaminophen with caffeine are not antidepressants and won’t address the condition.

When a person with depression does not respond adequately to a first-line antidepressant at a therapeutic dose, increasing the depth of pharmacologic strategy is often the next move. Adding a second antidepressant with a different mechanism can yield a greater effect. Mixing an SSRI with a serotonin-norepinephrine reuptake inhibitor, such as venlafaxine or duloxetine, increases both serotonin and norepinephrine activity, targeting multiple neurotransmitter systems to enhance mood improvement. This dual-action approach is a common second-line step for resistant or partial-response depression.

It’s important to monitor for increased side effects and risks like serotonin syndrome with this combination, hence it’s typically done under close supervision. In contrast, simply raising the SSRI dose may not provide additional benefit and can heighten adverse effects, benzodiazepines don’t treat the core depressive symptoms on their own, and acetaminophen with caffeine are not antidepressants and won’t address the condition.